# | Title | Journal | Year | Citations |
---|
1 | Optical properties of biological tissues: a review | Physics in Medicine and Biology | 2013 | 2,743 |
2 | Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report | Journal of Allergy and Clinical Immunology | 2010 | 1,614 |
3 | Guidelines of care for the management of atopic dermatitis | Journal of the American Academy of Dermatology | 2014 | 970 |
4 | The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis | Experimental Dermatology | 2001 | 897 |
5 | Guidelines of care for the management of atopic dermatitis | Journal of the American Academy of Dermatology | 2014 | 889 |
6 | Guidelines of care for the management of atopic dermatitis | Journal of the American Academy of Dermatology | 2014 | 695 |
7 | CIP2A Inhibits PP2A in Human Malignancies | Cell | 2007 | 662 |
8 | Eczema Prevalence in the United States: Data from the 2003 National Survey of Children's Health | Journal of Investigative Dermatology | 2011 | 612 |
9 | Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention | Journal of Allergy and Clinical Immunology | 2014 | 594 |
10 | Circulating Th17, Th22, and Th1 Cells Are Increased in Psoriasis | Journal of Investigative Dermatology | 2010 | 522 |
11 | Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial | Lancet, The | 2016 | 471 |
12 | Th17 Cytokines Stimulate CCL20 Expression in Keratinocytes In Vitro and In Vivo: Implications for Psoriasis Pathogenesis | Journal of Investigative Dermatology | 2009 | 410 |
13 | Gene for Familial Psoriasis Susceptibility Mapped to the Distal End of Human Chromosome 17q | Science | 1994 | 403 |
14 | Guidelines of care for the management of primary cutaneous melanoma | Journal of the American Academy of Dermatology | 2019 | 400 |
15 | Consensus Statement on Diagnostic Criteria for PHACE Syndrome | Pediatrics | 2009 | 361 |
16 | Mental health comorbidity in patients with atopic dermatitis | Journal of Allergy and Clinical Immunology | 2013 | 360 |
17 | Recombinant interferon gamma therapy for atopic dermatitis | Journal of the American Academy of Dermatology | 1993 | 288 |
18 | Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phaseIIItrials | British Journal of Dermatology | 2020 | 277 |
19 | Melanocytes as Instigators and Victims of Oxidative Stress | Journal of Investigative Dermatology | 2014 | 270 |
20 | Substance P selectively activates TNF-alpha gene expression in murine mast cells. | Journal of Immunology | 1993 | 268 |
21 | Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: a multicentre survey | British Journal of Dermatology | 1998 | 267 |
22 | Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults | Journal of the American Academy of Dermatology | 2016 | 251 |
23 | Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study | Journal of the American Academy of Dermatology | 2019 | 249 |
24 | Substance P selectively activates TNF-alpha gene expression in murine mast cells | Journal of Immunology | 1993 | 231 |
25 | Cellular origin of the dermal-epidermal basement membrane | Developmental Dynamics | 1993 | 222 |
26 | Elevated leukocyte cyclic AMP—phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP—agonist hyporesponsiveness | Journal of Allergy and Clinical Immunology | 1982 | 217 |
27 | IL-23–Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A | Journal of Immunology | 2011 | 212 |
28 | Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomised, double-blind, placebo-controlled, phase II regimen-finding study | British Journal of Dermatology | 2012 | 199 |
29 | Type 4 Phosphodiesterase Inhibitors Have Clinical and In Vitro Anti-inflammatory Effects in Atopic Dermatitis | Journal of Investigative Dermatology | 1996 | 195 |
30 | Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study | Journal of Allergy and Clinical Immunology | 2018 | 195 |
31 | Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis | JAMA Dermatology | 2020 | 194 |
32 | IL-23 and IL-17A, but Not IL-12 and IL-22, Are Required for Optimal Skin Host Defense against Candida albicans | Journal of Immunology | 2010 | 193 |
33 | Persistence of atopic dermatitis (AD): A systematic review and meta-analysis | Journal of the American Academy of Dermatology | 2016 | 186 |
34 | Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial | Lancet, The | 2020 | 178 |
35 | When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council | Journal of the American Academy of Dermatology | 2017 | 170 |
36 | Atopic dermatitis in the pediatric population | Annals of Allergy, Asthma and Immunology | 2021 | 170 |
37 | A systematic review of Investigator Global Assessment (IGA) in atopic dermatitis (AD) trials: Many options, no standards | Journal of the American Academy of Dermatology | 2016 | 162 |
38 | A pilot study of emollient therapy for the primary prevention of atopic dermatitis | Journal of the American Academy of Dermatology | 2010 | 161 |
39 | Eosinophilic Pustular Folliculitis In Infancy | Pediatric Dermatology | 1984 | 158 |
40 | The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-co | British Journal of Dermatology | 2016 | 157 |
41 | Amelanotic melanoma: The great masquerader | Journal of the American Academy of Dermatology | 2000 | 156 |
42 | SUPPRESSED CELL-MEDIATED IMMUNITY IN TWO ADULTS WITH ATOPIC DERMATITIS | British Journal of Dermatology | 1972 | 155 |
43 | Risk for PHACE Syndrome in Infants With Large Facial Hemangiomas | Pediatrics | 2010 | 155 |
44 | Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum | Journal of Allergy and Clinical Immunology | 2010 | 149 |
45 | Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles | Journal of the American Academy of Dermatology | 2010 | 148 |
46 | Prevalence and relevance of allergic reactions in patients patch tested in North America—1984 to 1985 | Journal of the American Academy of Dermatology | 1989 | 138 |
47 | T-Helper 17 Cells in Psoriatic Plaques and Additional Genetic Links between IL-23 and Psoriasis | Journal of Investigative Dermatology | 2008 | 138 |
48 | Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme | British Journal of Dermatology | 2004 | 136 |
49 | Immunological reactivity in dermatophytosis | British Journal of Dermatology | 2006 | 134 |
50 | Tumor-initiating cells establish an IL-33–TGF-β niche signaling loop to promote cancer progression | Science | 2020 | 134 |